Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
Cancer Chemotherapy and Pharmacology|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Research Square|September 11, 2023
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Cancer Medicine|November 16, 2024
Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All-Payer Claims Database Compared With Gold-Standard AbstractionAlzina Koric, Chun-Pin Esther Chang, Shane Lloyd, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2020
Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative studyTeresa M Salgado, Caroline S Quinn, Emily K Krumbach, et al.
Journal of Geriatric Oncology|October 23, 2021
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty toolElizabeth A Brem, Hongli Li, Anne W Beaven, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
British Journal of Pharmacology|January 2, 2026
Aromatase inhibitors induce pain-like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterizationMartial Caillaud, Sara M Herz, Eda Koseli, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|May 30, 2023
Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative reviewKen B Johnson, Anukriti Sharma, N Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Cancer Chemotherapy and Pharmacology|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Research Square|September 11, 2023
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Cancer Medicine|November 16, 2024
Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All-Payer Claims Database Compared With Gold-Standard AbstractionAlzina Koric, Chun-Pin Esther Chang, Shane Lloyd, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2020
Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative studyTeresa M Salgado, Caroline S Quinn, Emily K Krumbach, et al.
Journal of Geriatric Oncology|October 23, 2021
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty toolElizabeth A Brem, Hongli Li, Anne W Beaven, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
British Journal of Pharmacology|January 2, 2026
Aromatase inhibitors induce pain-like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterizationMartial Caillaud, Sara M Herz, Eda Koseli, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|May 30, 2023
Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative reviewKen B Johnson, Anukriti Sharma, N Lynn Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Pageof 24